Traws Pharma receives Nasdaq delisting notice for bid price below $1.00

Traws Pharma, Inc.

• Nasdaq notified Traws Pharma on July 29, 2026, of non-compliance with minimum bid price rule.
• Company has 180 days, until January 25, 2027, to regain compliance by closing at $1.00+ for 10 consecutive days.
• If not cured, Nasdaq may grant a second 180-day period if other listing standards are met.
• Company intends to monitor bid price and consider available options to regain compliance.
• Listing remains effective during the compliance period; failure could lead to delisting.